Offering a non-invasive strategy for analyzing fetal DNA from maternal blood, it truly is contributing mainly to the majority holding in the market, which is supported by its efficiency in prenatal diagnosis. Because the NIPT market expands, entrenched corporations are bolstered by important RD i